{
  "created_at": "Mon Aug 02 4:38:5 +0000 2021",
  "id_str": "1422021862456967169",
  "full_text": "Advisers to the FDA and former officials predict that full approval of Pfizer’s Covid-19 vaccine—currently authorized for emergency use—could come in September or October https://t.co/i1qJYjwzfb",
  "display_text_range": [
    0,
    194
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/i1qJYjwzfb",
        "expanded_url": "https://on.wsj.com/3ls6Mjg",
        "display_url": "on.wsj.com/3ls6Mjg",
        "indices": [
          171,
          194
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 29,
  "favorite_count": 95,
  "possibly_sensitive": false,
  "original_created_at": "Mon Aug 02 02:30:06 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "FDAのアドバイザーや元職員は、ファイザー社のCovid-19ワクチン（現在は緊急用に認可されている）の完全な認可は、9月か10月になるだろうと予測しています。https://t.co/i1qJYjwzfb"
    },
    {
      "locale": "zh",
      "full_text": "美国食品和药物管理局的顾问和前官员预测，辉瑞公司的Covid-19疫苗--目前被授权用于紧急用途--可能会在9月或10月获得全面批准https://t.co/i1qJYjwzfb。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "美國食品和藥物管理局的顧問和前官員預測，輝瑞公司的Covid-19疫苗--目前被授權用於緊急用途--可能會在9月或10月獲得全面批准https://t.co/i1qJYjwzfb。"
    }
  ]
}